ESPR icon

Esperion Therapeutics
ESPR

Overview Fund Activity

182 hedge funds and large institutions have $1.64B invested in Esperion Therapeutics in 2020 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 66 increasing their positions, 41 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
182
Holders Change
+17
Holders Change %
+10.3%
% of All Funds
3.74%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.08%
New
40
Increased
66
Reduced
41
Closed
23
Calls
$47.6M
Puts
$35.5M
Net Calls
+$12.1M
Net Calls Change
+$16.5M

Top Buyers

1
State Street
State Street
Massachusetts
$89.7M
2
Millennium Management
Millennium Management
New York
$27.2M
3
APM
Avidity Partners Management
Texas
$28.7M
4
WA
Wasatch Advisors
Utah
$63.9M
5
BG
Bellevue Group
Switzerland
$272M

Top Sellers

1
Balyasny Asset Management
Balyasny Asset Management
Illinois
$3.2M
2
RPAM
Rhenman & Partners Asset Management
Sweden
$21.8M
3
Deutsche Bank
Deutsche Bank
Germany
$708K
4
Vanguard Group
Vanguard Group
Pennsylvania
$121M
5
Citadel Advisors
Citadel Advisors
Florida
$4.16M
Name Holding Trade Value Shares
Change 		Shares
Change %
AA
201
Advisory Alpha
Michigan
– -$6.24K -160 Closed
AF
202
Advisornet Financial
Minnesota
– -$3K -100 Closed
TFA
203
Toth Financial Advisory
Virginia
– -$1K -25 Closed
FWM
204
Filbrandt Wealth Management
Wisconsin
– -$1K -25 Closed
5 6 7 8
9